Weiss Multi-Strategy Advisers’s Standard BioTools LAB Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,000	Closed	-$74K	–	744
2020 Q3	$74K	Sell	10,000 -10,044	-50%	-$69.3K	﹤0.01%	543
2020 Q2	$80K	Sell	20,044 -6,718	-25%	-$23.4K	﹤0.01%	526
2020 Q1	$68K	Sell	26,762 -73,238	-73%	-$241K	﹤0.01%	402
2019 Q4	$348K	Hold	100,000	–	–	0.01%	555
2019 Q3	$463K	Sell	100,000 -10,000	-9%	-$78.8K	0.01%	498
2019 Q2	$1.35M	Sell	110,000 -10,000	-8%	-$127K	0.04%	352
2019 Q1	$1.59M	Sell	120,000 -5,000	-4%	-$52.7K	0.04%	353
2018 Q4	$1.08M	Hold	125,000	–	–	0.04%	288
2018 Q3	$936K	Sell	125,000 -8,001	-6%	-$56.9K	0.02%	403
2018 Q2	$793K	Sell	133,001 -31,999	-19%	-$182K	0.02%	465
2018 Q1	$964K	Buy	165,000 +25,000	+18%	+$164K	0.03%	421
2017 Q4	$825K	Buy	140,000 +65,000	+87%	+$356K	0.02%	457
2017 Q3	$378K	Sell	75,000 -20,000	-21%	-$84.1K	0.01%	444
2017 Q2	$384K	Sell	95,000 -5,000	-5%	-$23.7K	0.02%	468
2017 Q1	$569K	Hold	100,000	–	–	0.02%	440
2016 Q4	$728K	Buy	100,000 +70,000	+233%	+$440K	0.04%	302
2016 Q3	$240K	Buy	30,000 +8,130	+37%	+$74.7K	0.01%	388
2016 Q2	$197K	Sell	21,870 -18,130	-45%	-$170K	0.02%	376
2016 Q1	$323K	Buy	40,000 +30,000	+300%	+$216K	0.01%	409
2015 Q4	$108K	Hold	10,000	–	–	0.01%	366
2015 Q3	$81K	Sell	10,000 -10,000	-50%	-$157K	﹤0.01%	381
2015 Q2	$484K	Buy	+20,000	New	+$631K	0.02%	382

Other funds holding LAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACM

Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Weiss Multi-Strategy Advisers's LAB Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Standard BioTools (LAB) in Q4 2020, closing a stake of 10,000 shares — an estimated $74K sold.

Weiss Multi-Strategy Advisers first reported a position in LAB in Q2 2015 and held it in 22 quarters. The position peaked at $1.59M in Q1 2019. 145 funds tracked by Wall St. Rank hold LAB as of Q4 2020.

Weiss Multi-Strategy Advisers reported no remaining Standard BioTools position as of Q4 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 10,000 Standard BioTools shares in Q4 2020, an estimated $74K.
Weiss Multi-Strategy Advisers first reported a position in Standard BioTools in Q2 2015 and held it in 22 quarters.
Weiss Multi-Strategy Advisers's Standard BioTools position peaked at $1.59M in Q1 2019.
145 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.